Mortality and Related Risk Factors After Hip Arthroplasty

Overview

The patients who underwent hip arthroplasty in our hospital from January 2017 to December 2020 were reviewed. The perioperative data were collected, and then the mortality was calculated and the risk factors were analyzed.

Full Title of Study: “Mortality and Related Risk Factors After Hip Arthroplasty, a Retrospective Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: August 4, 2023

Arms, Groups and Cohorts

  • All patients were reviewed

Clinical Trial Outcome Measures

Primary Measures

  • Risk factors of mortality one year after operation
    • Time Frame: From about even days before operation to 12 months after operation

Secondary Measures

  • Risk factors of lower activities of daily living score at 12 months after operation
    • Time Frame: From about even days before operation to 12 months after operation

Participating in This Clinical Trial

Inclusion Criteria

  • All patients undergoing hip arthroplasty in Renji Hospital during 2017.1-2020.12 Exclusion Criteria:

  • Patients who did not undergo surgery after admission Age < 18 years Patients undergoing the second operation

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • RenJi Hospital
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Leilei WANG, master, 8618801966298, wangleilei@renji.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.